
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Syncona Limited | SYNC | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
89.50 | 88.30 | 89.50 | 88.10 | 87.00 |
Industry Sector |
---|
EQUITY INVESTMENT INSTRUMENTS |
Top Posts |
---|
Posted at 23/3/2025 19:17 by hugepants sigmund freud6 Mar '25 - 14:41 - 740 of 7410 0 0 the biggest problem is valuing the underlying assets. you really do have to trust them that the value is what they say it is. I added on Friday at under 90p. Currently valued at 50% of latest NAV (to end Dec 2024) and they have 38p per share in liquid assets/cash. The company claim recent portfolio company financings validate the NAV. "...Melanie Gee, Chair of Syncona Limited, commented: "The Board remains frustrated by the share price performance and widening discount to NAV. The fundamentals of the portfolio are robust given the rebalancing to later stage companies and the number of recent financings supported by third party investors that externally validate the valuation of these portfolio companies. The Board is confident that the portfolio is well placed to deliver strong risk adjusted returns over time..." Also check out INOV's news last week on their Araris Biotech investment. Taken out at an initial 7.2* investment and up to a possible 20* based on subsequent performance. I'm sure SYNC have a few gems in the portfolio. Probably a few zeros as well but that's what you'd expect. |
Posted at 19/2/2025 14:55 by spectoacc Nice thing with SYNC is that if the tap has indeed ended/stopped, the 150,000 shares a day they buy in start to make a difference.207k traded in total today by nearly 3pm. |
Posted at 18/2/2025 08:22 by spectoacc Seems turned off for now, but with no great indication that's it (no huge trade or Holdings RNS).Convinced SYNC is cheap, but can't say it won't be 80p in 6 months time :) I reckon it'd be trading in the £1.20's without the seller, & will get back there eventually. |
Posted at 05/2/2025 08:52 by spectoacc RICA, CGT, or PNL all seem good at the right moments, but they've barely beaten cash for a long while now. Makes me think I can do better :) But as you say, sitting on hands is sometimes better, and timing is both impossible, and everything.SYNC will come good - am almost sure of it - but when, and how low first, who knows. |
Posted at 05/2/2025 08:49 by cousinit @specto thanks - I hold all of those as recent-ish buys but they haven't quite made it into the top 5 yet. Can't quite bring myself to aggressively sell down some of the other growthier alternatives like PE (every time I have trimmed them and bought renewables, sitting on my hands would have been more beneficial! But that also goes for topping up SYNC... )CGT seems to be limiting IT exposure to keep liquidity high (I guess partly because of the buyback) so seems to be caught a bit between two stools. I have bought some RICA, just in case things go pear shaped. |
Posted at 05/2/2025 08:23 by spectoacc Agreed re Achilles, looked bad but actually good :)@CousinIT - I'd been pretty defensively positioned, had ERNS and CGT in top 5 holdings, as well as some CSH2, gold, & Gilts elsewhere. Had a Gilt maturity, sold out completely of CSH2, almost sold out of ERNS & CGT. All into risk assets. Top 5 now SEIT, ASLI, FGEN, TRIG, FSFL. Only ASLI non-risk. I might be wrong - very wrong - and this could be the end of renewables. If not, there's a lot in the prices as you say, & paid to wait. Saying that, obviously down on all atm. (SYNC, fwiw, now my 7th largest holding. Can absolutely go lower, by tens of pence, but IMO artificially down here due to fund manager merger/major seller). Edit - was a time I had 4 REITs in Top 5, and long before that 4 PE - but logic says eventually it'll go badly wrong. |
Posted at 04/2/2025 16:07 by spectoacc Trouble is, the size of the stake is so large, even a few million probably doesn't signal the end of it.But who cares - I'm in SYNC for the mid term, it's cheap IMO, & added again today. Good luck holders. |
Posted at 14/1/2025 14:34 by sigmund freud bought at 93.5pbiotech is bombed out right now sync on discount of 48% (!) so it is a leveraged play on a bombed out sector. autolus CRT drug looks the best in the business, for a terrible condition that a lot of young people get, so there is motivation to get them better and to pay for it. i like some of the other investee research but lot of it is just that and a phase 3 trial can always crash and burn. so where next for price? the chart is interesting. it has been in a descending channel for some time, with an acceleration towards the bottom. however it is at a crucial point, with a likely marked move up or down soon. this is entirely a guess, but i am saying to the upside! free stock charts from uk.advfn.com |
Posted at 07/1/2025 16:32 by spectoacc Remain convinced there's value in SYNC, but from what level..Still a holder. |
Posted at 11/11/2024 13:22 by spectoacc Not sure they've sold any yet - they've said they're holding the APAX position until it re-rates for eg, wouldn't be surprised if same with SYNC. ie a longer-term seller, but not a firesale.Happy to sit in SYNC - if they did sell & tank it, I'd buy more. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions